This brand name is authorized in Nigeria.
The drug AUROXETIL contains one active pharmaceutical ingredient (API):
1
|
UNII
Z49QDT0J8Z - CEFUROXIME AXETIL
|
|
Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-4002 | Tablet | AUROXETIL 250MG TAB 250 mg 1X10s | 44 RNW-PP-293515 AUROXETIL 250MG CEFUROXIME AXETIL 250MG Cefuroxime Axetil Ph.Eur. equivalent to Cefuroxime 250 mg. Sodium Lauryl 5mg, Cellulose Micro crystalline 135.28mg A4-4002 Drugs Imported Products 1X10s POM 1 1/3/2023 PHILLIPS PHARMACEUTICALS (NIGERIA) LIMITED, PLOT 122-123 AFRIPRINT ESTATE, ISOLO 8035493198 harriet.okika@phillipsnigeria.com Aurobindo Pharma Ltd, Aurobindo Pharma Ltd Unit VI Survey No 329/39 & 329/47 Chitkul( V) , Patancheru Mandal Sanga Reddy District Telangana State India, India | 25/05/2023 |
| A4-4190 | Tablet | AUROXETIL 500MG TABLETS TAB 500 mg 1X10s | 17 RNW-PP-293431 AUROXETIL 500MG TABLETS CEFUROXIME AXETIL 500MG Cefuroxime 500mg, Cellulose Microcrystalline 135.28mg, Sodium Lauryl 5mg. A4-4190 Drugs Imported Products 110s POM 1 12/29/2022 PHILLIPS PHARMACEUTICALS (NIGERIA) LIMITED, PLOT 122-123 AFRIPRINT ESTATE, ISOLO 8035493198 samson.omattah@phillipsnigeria.com Aurobindo Pharma Ltd, Aurobindo Pharma Ltd Unit VI Survey No 329/39 & 329/47 Chitkul( V) , Patancheru Mandal Sanga Reddy District Telangana State India, India | 06/07/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01DC02 | Cefuroxime | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DC Second-generation cephalosporins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-4002, A4-4190 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.